Celltrion Healthcare to expand product lineup, direct sales network after IPO
IndustryJul 16, 2017
Celltrion Healthcare, the sales and marketing unit of Celltrion, said Friday that it would actively seek out new drug candidates to broaden its product portfolio as well as build stronger direct sales routes globally to boost profits. The firm’s new direction was announced by its CEO Kim Man-hoon during a press conference held in Seoul ahead of the company’s scheduled public listing on Korea’s secondary bourse Kosdaq on July 28.According to Kim, Celltrion Healthcare is looking for overseas inves